Science Atlas

How We Know What We Know
Sign In
Text size
100%
Theme
Scientist

Ibn Sina

Medicine

Ibn Sina, known in Europe as Avicenna, wrote The Canon of Medicine around 1025, a five volume systemization of Greek, Indian and Islamic medical knowledge that set out rules for testing a drug's effect: try it on an uncomplicated case, observe the same result across repeated trials, and rule out other causes before crediting the drug. The Canon remained a standard medical textbook in European universities into the seventeenth century. He also wrote extensively on logic and metaphysics, and served as a court physician and administrator across several Persian and Central Asian courts. This description is adapted from Wikipedia contributors under CC BY-SA 4.0; changes were made. https://creativecommons.org/licenses/by-sa/4.0/

Facts
Birth YearSourced to the subject's own account
980 1
Death Date
1037-06-24 2
Death YearSourced to the subject's own account
1037 1
FieldSourced to the subject's own account
Medicine 1
Death Place
Hamadan, Iran 2
Notable Work
Al-isharat wa al-tanbihat 2
Notable Work
Canon of Medicine 2
Notable Work
The Book of Healing 2
Birthplace
Afshona, Uzbekistan 2
Field
Field (category)Sourced to the subject's own account
Medicine 1
Connections

Works In

Medicine, Disciplines
In the Other Atlases
Sources
1. Ibn Sina (Wikipedia)
WikipediaLead section
Quote, Lead section
Ibn Sina (c. 980-22 June 1037), commonly known in the West as Avicenna ( A(H)V-ih-SEN-ə), was a preeminent philosopher and physician of the Muslim world.
View the Source
2. Ibn Sina (Wikidata)
  • P570 (date of death): full date
    +1037-06-18T00:00:00Z
  • P20 (place of death): Hamadan, Iran
    Q28587
  • P19 (place of birth): Afshona, Uzbekistan
    Q4072887
  • P800 (notable work): Canon of Medicine
    Q466060
  • P800 (notable work): The Book of Healing
    Q1030940
  • P800 (notable work): Al-isharat wa al-tanbihat
    Q22948618
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.